EPS for Quorum Health Corp (QHC) Expected At $

Bruno Cirelli
Agosto 12, 2017

Credit Suisse Group reiterated a "neutral" rating and set a $3.25 price target (down previously from $5.00) on shares of Quorum Health Corporation in a report on Wednesday, May 17th. Zacks Investment Research now has $4.50 price objective on the stock.

Media headlines about Quorum Health Corporation (NYSE:QHC) have been trending somewhat positive on Monday, according to Accern. It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals.

Several brokerages recently commented on QHC. Finally, Morgan Stanley assumed coverage on shares of Quorum Health Corporation in a research note on Tuesday, June 6th. They issued an "underweight" rating and a $3.00 price target on the stock. The rating was maintained by Deutsche Bank on Wednesday, April 5 with "Hold". Finally, Ameriprise Financial Inc. boosted its position in Quorum Health Corporation by 1.8% in the second quarter. The analysts, on average, are forecasting a $2.56 price target, but the stock is already up 12.5% from its recent lows.

About 4,100 shares traded or Infinity% up from the average.

Quorum Health Corporation (QHC), a part of Healthcare sector and belongs to Hospitals industry; ended its day with gain 0.96% and finalized at the price of $3.14. The company has market cap of $94.25 million.

Quorum Health Corp (NYSE:QHC) has declined 66.10% since August 10, 2016 and is downtrending. After $-0.85 actual earnings per share reported by Quorum Health Corp for the previous quarter, Wall Street now forecasts -35.29 % EPS growth. Quorum Health Corporation had a negative net margin of 7.13% and a negative return on equity of 57.09%. The business had revenue of $530.15 million for the quarter, compared to analyst estimates of $513.50 million. During the same period a year ago, the company earned ($0.82) earnings per share. Quorum Health Corporation's for the quarter end, revenue was upwards of.1% on a YOY basis. If you are reading this report on another domain, it was stolen and republished in violation of US and worldwide copyright & trademark law. The original version of this report can be accessed at https://weekherald.com/2017/08/12/quorum-health-corporation-qhc-lifted-to-buy-at-zacks-investment-research-updated-updated.html.

In related news, insider Thomas Daniel Miller acquired 185,000 shares of the stock in a transaction that occurred on Thursday, May 18th. The shares were purchased at an average price of $2.85 per share, with a total value of $527,250.00. About 352,211 shares traded or 53.95% up from the average. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Shaheed Koury purchased 8,500 shares of the business's stock in a transaction on Thursday, May 25th.

Analysts are speculating a 196.3% move, based on the high target price ($4) for the shares that is set to reach in the next 12 months. The biggest holder now is Thomas D. Miller who owns 814,139 shares (2.69% of those outstanding), whilst Michael J. Culotta holds 232,385 (0.77% of shares outstanding) and Martin Dewayne Smith holds 151,716 (0.50% of shares outstanding). The disclosure for this purchase can be found here.

Other investment firms and many large funds lately modified to their stake in The corporation. Comerica Bank now owns 31,340 shares of the company's stock valued at $285,000 after buying an additional 1,534 shares during the period. Dimensional Fund Advisors LP raised its stake in Quorum Health Corporation by 17.8% in the fourth quarter. Menta Capital LLC now owns 118,427 shares of the company's stock valued at $491,000 after buying an additional 90,621 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Quorum Health Corporation by 111.3% in the first quarter. Metropolitan Life Insurance Co. Acadian Asset Management LLC raised its stake in shares of Quorum Health Corporation by 130.4% in the first quarter. Norges Bank purchased a fresh position in stocks of Quorum Health Corporation throughout the Q4 valued about $1,150,000. On average, equities analysts anticipate that Quorum Health Corporation will post ($1.63) EPS for the current fiscal year. The hedge fund held 19,217 stocks of the firms shares after disposing 2,083 shares through out the quarter.

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE